Correspondence 0001628280-24-040031 from Akebia Therapeutics, Inc. (AKBA) (CIK 0001517022) (AKBA)
Akebia Therapeutics, Inc. (AKBA) (CIK 0001517022)
Date: Sept. 10, 2024 · CIK: 0001517022 · Accession: 0001628280-24-040031
AI Filing Summary & Sentiment
File numbers found in text: 333-281903
Letter
Document
September 10, 2024
VIA EDGAR SUBMISSION
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549
Attention: Lauren Hamill
Re: Akebia Therapeutics, Inc.
Registration Statement on Form S-3
Filed September 3, 2024
File No. 333-281903
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Akebia Therapeutics, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-281903), so that it may become effective at 4:30 p.m., Eastern time, on September 12, 2024, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff.
Very truly yours,
By: /s/ John P. Butler
Show Raw Text
CORRESP 1 filename1.htm Document September 10, 2024 VIA EDGAR SUBMISSION Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549 Attention: Lauren Hamill Re: Akebia Therapeutics, Inc. Registration Statement on Form S-3 Filed September 3, 2024 File No. 333-281903 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Akebia Therapeutics, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-281903), so that it may become effective at 4:30 p.m., Eastern time, on September 12, 2024, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff. Very truly yours, By: /s/ John P. Butler John P. Butler President and Chief Executive Officer